The Report
Verified funding, headquarters, and leadership news from the world's most innovative businesses
164 reports and counting
ProtaGene Appoints Matthias Bucerius Chief Executive Officer
ProtaGene appointed former Merck KGaA CDMO senior vice president Matthias Bucerius as CEO, effective immediately, to work with its Presidents on timelines, data quality, and analytical science.
Emerald Clinical Trials Appoints Michael Stibilj Chief Executive Officer
Emerald Clinical Trials appointed Michael Stibilj CEO to lead its next phase of growth, with Interim CEO Glenn Kerkhof remaining on the Board and advising the company.
Legend Biotech Appoints Ingrid Zhang Chief Executive Officer
Legend Biotech appointed former Novartis International Chief Commercial Officer Ingrid Zhang as CEO, succeeding Interim CEO Alan Bash, to guide the cell therapy company’s next phase of growth.
Enginprime Medical Raises $12M Series A for Percutaneous Heart Pump Devices
Enginprime Medical closed a $12M Series A led exclusively by Qiming Venture Partners to fund the China registration trial of its OpusOne percutaneous ventricular assist device.
Tessera Therapeutics Appoints Joseph Romanelli President and Chief Executive Officer
Tessera Therapeutics appointed Joseph Romanelli, most recently a Merck executive, as President and CEO, succeeding Michael Severino, as the company shifts from platform innovation toward a broad portfolio of Gene Writing medicines.
Crystalys Therapeutics Raises $130M Series B for Gout Drug Development
Crystalys Therapeutics raised an oversubscribed $130 million Series B led by Frazier Life Sciences to advance clinical development and commercialization preparation of dotinurad for gout.
Meshy Raises Nearly $400M Series B at a $1.5B Valuation
AI 3D-generation company Meshy raised nearly $400 million in a Series B at a $1.5 billion valuation, the largest disclosed round in its category.
China Unicom Raises $50B in Public
China Unicom, a Telecommunications company based in 21 Financial Street, Beijing 100033, China, has raised $50B in Public at a $55B valuation led by Public.
China Telecom Raises $80B in Public
China Telecom, a Telecommunications company based in 31 Jinrong Street, Beijing 100033, China, has raised $80B in Public at a $85B valuation led by Public.
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.